Therapy for chronic hepatitis B: the earlier, the better?
- 1 October 2004
- journal article
- review article
- Published by Elsevier in Trends in Microbiology
- Vol. 12 (10), 431-433
- https://doi.org/10.1016/j.tim.2004.08.007
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Residual integrated viral DNA after hepadnavirus clearance by nucleoside analog therapyProceedings of the National Academy of Sciences, 2003
- Hepatocyte turnover during resolution of a transient hepadnaviral infectionProceedings of the National Academy of Sciences, 2003
- Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis BNew England Journal of Medicine, 2003
- Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis BNew England Journal of Medicine, 2003
- Histological outcome during long-term lamivudine therapyGastroenterology, 2003
- Chronic hepatitis BHepatology, 2001
- Long‐Term Entecavir Treatment Results in Sustained Antiviral Efficacy and Prolonged Life Span in the Woodchuck Model of Chronic Hepatitis InfectionThe Journal of Infectious Diseases, 2001
- Kinetics of Hepadnavirus Loss from the Liver during Inhibition of Viral DNA SynthesisJournal of Virology, 2001
- Chronic carriers of hepatitis B virus who clear hepatitis B surface antigen: Are they really “off the hook”?Hepatology, 1998
- Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cellsCell, 1986